샘플 요청 목록

 카트 문의
시장보고서
상품코드
1757608

세계의 유전자 전달 기술 시장

Gene Delivery Technologies
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 370 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 유전자 전달 기술 시장은 2030년까지 49억 달러에 도달

2024년에 30억 달러로 추정되는 세계의 유전자 전달 기술 시장은 2024-2030년에 CAGR 8.7%로 성장하며, 2030년에는 49억 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 생물학적 모드는 CAGR 10.3%를 기록하며, 분석 기간 종료시에는 32억 달러에 달할 것으로 예측됩니다. 화학적 모드 부문의 성장률은 분석 기간 중 CAGR 5.8%로 추정됩니다.

미국 시장은 8억 550만 달러로 추정, 중국은 CAGR 13.9%로 성장 예측

미국의 유전자 전달 기술 시장은 2024년에 8억 550만 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 2030년까지 11억 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년의 CAGR은 13.9%입니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 4.3%와 8.4%로 예측됩니다. 유럽에서는 독일이 CAGR 5.8%로 성장할 것으로 예측됩니다.

세계의 "유전자 전달 기술" 시장 - 주요 동향 및 촉진요인 정리

유전자 전달 기술이 현대 치료와 유전체 의학의 핵심인 이유는 무엇인가?

유전자 전달 기술은 유전자 치료, 유전자 편집, 맞춤형 의료의 근본적인 원동력으로서 생의학 연구와 임상 치료의 전망에 혁명을 불러일으키고 있습니다. 이러한 기술은 DNA, RNA 또는 CRISPR-Cas 시스템과 같은 유전 물질을 표적 세포에 안전하고 효율적으로 도입하는 것을 용이하게 하며, 유전적 결함을 교정하거나 유전자 발현을 조절하거나 질병 모델을 만드는 데 필수적인 과정입니다. 유전성 질환, 암, 바이러스 감염에 대한 관심이 높아지면서 신뢰할 수 있는 유전자 도입 플랫폼에 대한 수요가 급증하고 있습니다. 기존 의약품과 달리 유전자 기반 중재를 효과적이고 안전하게 수행하기 위해서는 정확하고 표적화된 전달이 필요하므로 바이러스 벡터(아데노 부속 바이러스, 렌티바이러스, 레트로바이러스 등)와 비바이러스 방식(지질 나노입자, 일렉트로포레이션, 폴리머 기반 시스템 등)의 중요성이 대두되고 있습니다. 폴리머 기반 시스템 등) 모두 중요성이 커지고 있습니다. 최근 COVID-19 mRNA 백신의 성공은 지질 기반 전달에 의존하여 유전자 전달 툴의 상업적 및 치료적 실행 가능성을 더욱 검증하고 전례 없는 연구 자금과 이종 산업 간 협업을 촉발시켰습니다.

유전자 도입의 안전성, 정확성, 확장성을 높이는 신기술은?

기술 혁신은 유전자 도입 시스템의 능력을 획기적으로 발전시켜 면역원성, 전달 효율, 조직 특이성과 같은 과거의 한계를 극복하고 있습니다. 바이러스 벡터의 경우, 캡시드를 조작한 차세대 아데노부수체 바이러스(AAV)는 개선된 트로피즘과 면역 반응 감소를 제공하여 혈우병, 망막 이영양증, 척수성 근위축증과 같은 질병에 대한 전신 적용을 더욱 안전하게 만들고 있습니다. 숙주 유전체에 삽입하는 것으로 알려진 렌티바이러스 벡터는 줄기세포 및 CAR-T 세포 치료에 최적화되고 있습니다. 비바이러스성에서는 지질 나노입자(LNP)가 특히 mRNA 기반 치료에서 고효율, 모듈화, 저독성을 제공하는 최전선으로 급부상하고 있습니다. 전기 천공 및 미세 유체 기반 시스템은 특히 자가 세포 치료에서 생체 외 적용으로 인기를 끌고 있습니다. 또한 pH, 효소 또는 외부 트리거(빛이나 초음파 등)에 반응하는 스마트 전달 플랫폼은 부위별 유전자 방출을 개선하기 위해 연구되고 있습니다. 이러한 기술 혁신은 치료 결과를 개선할 뿐만 아니라, 임상 및 상업적 출시에 필수적인 대규모 GMP 준수 제조를 지원합니다.

임상 파이프라인, 규제 동향, 산업 투자의 역할은?

암, 신경 및 희귀질환에 대한 유전자 치료 임상 파이프라인의 급속한 확장은 유전자 전달 기술 시장의 중요한 촉매제입니다. 미국 FDA 및 EMA와 같은 규제기관이 획기적인 지정을 받기 위한 심사 경로를 가속화함에 따라 수십 개의 유전자 기반 치료법이 임상 개발 단계에 있습니다. 이러한 규제 모멘텀은 스타트업, 바이오테크놀러지 기업, 제약사 모두 안전성, 재현성, 장기적 효능을 보장하는 전달 플랫폼에 대한 투자를 강화하도록 유도하고 있습니다. 전달 기술 개발 기업과 치료제 개발 기업의 합병, 라이선스 계약, R&D 협력이 급증하고 있는 것은 전달 시스템이 기술적 여분의 기술이 아닌 전략적 자산으로 인식되고 있다는 것을 보여줍니다. 또한 규제 당국의 지침은 벡터의 특성 평가, 생체내 분포, 면역 프로파일링에 대한 중요성을 점점 더 강조하고 있습니다. 한편, 국가 유전체 미션과 질병별 재단을 포함한 공공 및 민간 자금 지원 구상은 소외된 질병과 인구집단을 해결하기 위해 전달에 초점을 맞춘 연구를 지원하고 있으며, 이는 세계 시장 기회를 더욱 확대하는 데 기여하고 있습니다.

유전자 전달 기술의 세계 확장을 촉진하는 주요 성장 요인은 무엇인가?

세계 유전자 전달 기술 시장의 성장은 임상 혁신, 치료 수요, 생명공학의 발전에 기인한 여러 가지 상호 연관된 요인에 의해 주도되고 있습니다. 가장 중요한 것은 유전자 치료의 임상시험 및 승인 건수가 증가하고 있으며, 특정 질병 표적 및 환자 집단에 맞춘 견고하고 확장 가능한 전달 메커니즘이 필수적으로 요구되고 있다는 점입니다. 둘째, 단발성 질환에서 복잡한 암과 감염성 질환에 이르기까지 유전자 치료의 적응 범위가 넓어지고 있으므로 다양하고 적응성이 높은 전달 플랫폼의 개발이 필요합니다. 셋째, 합성생물학과 유전체 공학의 발전으로 더 큰 페이로드, 다중 유전자 편집, 엄격하게 제어된 발현 프로파일에 대응할 수 있는 정밀 전달 시스템의 필요성이 확대되고 있습니다. 넷째, 정부와 민간 부문의 유전자 의료에 대한 투자가 증가하면서 플랫폼 개발 및 상업화 경로가 가속화되고 있습니다. 마지막으로 mRNA 기반 치료제 및 백신의 성공은 비바이러스 전달 시스템 시장 잠재력을 입증하고 나노입자 공학, 고분자 과학 및 접합 화학의 추가 혁신을 촉진하고 있습니다. 이러한 요소들이 종합적으로 차세대 의료의 기초가 되는 유전자 전달 기술의 강력한 세계 확장을 지원하고 있습니다.

부문

모드(생물학적 모드, 화학적 모드, 물리학적 모드), 방법(생체 외법, 생체 내법, 체외법), 애플리케이션(유전자 치료 애플리케이션, 세포치료 애플리케이션, 백신 애플리케이션, 조사 애플리케이션)

조사 대상 기업의 예(합계 34 주목)

  • Alnylam Pharmaceuticals Inc.
  • Amgen Inc.
  • American Gene Technologies
  • AskBio(subsidiary of Bayer AG)
  • Astellas Gene Therapies
  • Beam Therapeutics Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • BioNTech SE
  • Bluebird Bio Inc.
  • Catalent, Inc.
  • CRISPR Therapeutics AG
  • Editas Medicine Inc.
  • ElevateBio
  • F. Hoffmann-La Roche AG
  • Genentech, Inc.
  • GenScript ProBio
  • Horizon Discovery Ltd.
  • Intellia Therapeutics Inc.
  • Johnson & Johnson

AI 통합

우리는 유효한 전문가 컨텐츠와 AI 툴에 의해 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 LLM나 업계 고유 SLM를 조회하는 일반적인 규범에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수입원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSA 25.07.03

Global Gene Delivery Technologies Market to Reach US$4.9 Billion by 2030

The global market for Gene Delivery Technologies estimated at US$3.0 Billion in the year 2024, is expected to reach US$4.9 Billion by 2030, growing at a CAGR of 8.7% over the analysis period 2024-2030. Biological Mode, one of the segments analyzed in the report, is expected to record a 10.3% CAGR and reach US$3.2 Billion by the end of the analysis period. Growth in the Chemical Mode segment is estimated at 5.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$805.5 Million While China is Forecast to Grow at 13.9% CAGR

The Gene Delivery Technologies market in the U.S. is estimated at US$805.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.1 Billion by the year 2030 trailing a CAGR of 13.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.3% and 8.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.8% CAGR.

Global "Gene Delivery Technologies" Market - Key Trends & Drivers Summarized

Why Are Gene Delivery Technologies at the Core of Modern Therapeutics and Genomic Medicine?

Gene delivery technologies are revolutionizing the landscape of biomedical research and clinical treatment, serving as the fundamental enablers for gene therapy, genome editing, and personalized medicine. These technologies facilitate the safe and efficient introduction of genetic material-DNA, RNA, or CRISPR-Cas systems-into target cells, a process essential for correcting genetic defects, modulating gene expression, or creating disease models. With the surge in interest surrounding genetic diseases, cancers, and viral infections, the demand for reliable gene delivery platforms has skyrocketed. Unlike traditional pharmaceuticals, gene-based interventions require precise and targeted delivery to be effective and safe, thus elevating the importance of both viral vectors (like adeno-associated virus, lentivirus, and retrovirus) and non-viral methods (such as lipid nanoparticles, electroporation, and polymer-based systems). The recent success of mRNA vaccines for COVID-19, which relied on lipid-based delivery, has further validated the commercial and therapeutic viability of gene delivery tools, sparking unprecedented research funding and cross-industry collaborations.

How Are Emerging Technologies Enhancing Safety, Precision, and Scalability in Gene Delivery?

Technological innovation is dramatically advancing the capabilities of gene delivery systems, addressing past limitations in immunogenicity, transfection efficiency, and tissue specificity. In viral vectors, new-generation adeno-associated viruses (AAVs) with engineered capsids are offering improved tropism and reduced immune responses, making them safer for systemic applications in diseases like hemophilia, retinal dystrophies, and spinal muscular atrophy. Lentiviral vectors, known for their integration into host genomes, are being optimized for stem cell and CAR-T cell therapies. On the non-viral front, lipid nanoparticles (LNPs) have surged to the forefront, especially in mRNA-based therapies, offering high efficiency, modular design, and low toxicity. Electroporation and microfluidic-based systems are gaining traction for ex vivo applications, particularly in autologous cell therapies. Additionally, smart delivery platforms responsive to pH, enzymes, or external triggers (e.g., light or ultrasound) are being explored to improve site-specific gene release. These innovations not only enhance therapeutic outcomes but also support large-scale, GMP-compliant manufacturing-critical for clinical and commercial deployment.

What Role Do Clinical Pipelines, Regulatory Trends, and Industry Investment Play?

The rapid expansion of gene therapy clinical pipelines across oncology, neurology, and rare diseases is a key catalyst for the gene delivery technologies market. Dozens of gene-based therapies are in advanced stages of clinical development, with regulatory bodies such as the U.S. FDA and EMA accelerating review pathways for breakthrough designations. This regulatory momentum is encouraging startups, biotech firms, and pharma giants alike to intensify investment in delivery platforms that ensure safety, reproducibility, and long-term efficacy. Mergers, licensing deals, and R&D collaborations between delivery tech developers and therapeutic companies have spiked, signaling a growing recognition of delivery systems as strategic assets rather than technical afterthoughts. Additionally, regulatory guidance is now increasingly emphasizing vector characterization, biodistribution, and immune profiling-areas directly tied to delivery mechanism design. Meanwhile, public and private funding initiatives, including national genomics missions and disease-specific foundations, are supporting delivery-focused research to address underserved diseases and populations, further expanding global market opportunities.

What Are the Key Growth Drivers Fueling the Global Expansion of Gene Delivery Technologies?

The growth in the global gene delivery technologies market is driven by several interconnected factors stemming from clinical innovation, therapeutic demand, and biotechnological advancement. Foremost is the increasing number of gene therapy trials and approvals, which inherently require robust and scalable delivery mechanisms tailored to specific disease targets and patient populations. Second, the broadening range of gene therapy indications-from monogenic disorders to complex cancers and infectious diseases-is necessitating the development of diverse and adaptable delivery platforms. Third, advances in synthetic biology and genome engineering are expanding the need for precision delivery systems that can accommodate larger payloads, multiplex gene edits, and tightly regulated expression profiles. Fourth, rising investment from both governments and the private sector in genetic medicine is accelerating platform development and commercialization pathways. Lastly, the success of mRNA-based therapeutics and vaccines has demonstrated the market potential for non-viral delivery systems, spurring further innovation in nanoparticle engineering, polymer science, and conjugation chemistry. These factors collectively underpin the robust global expansion of gene delivery technologies as a foundational pillar of next-generation medicine.

SCOPE OF STUDY:

The report analyzes the Gene Delivery Technologies market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Mode (Biological Mode, Chemical Mode, Physical Mode); Method (Ex Vivo Method, In Vivo Method, In Vitro Method); Application (Gene Therapy Application, Cell Therapy Application, Vaccines Application, Research Application)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • Alnylam Pharmaceuticals Inc.
  • Amgen Inc.
  • American Gene Technologies
  • AskBio (subsidiary of Bayer AG)
  • Astellas Gene Therapies
  • Beam Therapeutics Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • BioNTech SE
  • Bluebird Bio Inc.
  • Catalent, Inc.
  • CRISPR Therapeutics AG
  • Editas Medicine Inc.
  • ElevateBio
  • F. Hoffmann-La Roche AG
  • Genentech, Inc.
  • GenScript ProBio
  • Horizon Discovery Ltd.
  • Intellia Therapeutics Inc.
  • Johnson & Johnson

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Gene Delivery Technologies - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Advances in Viral and Non-Viral Vectors Drive Innovation in Gene Delivery Platforms
    • Rising R&D Investments in Gene Therapies Strengthen Business Case for Delivery Technologies
    • Emergence of mRNA and CRISPR Modalities Throws the Spotlight on Targeted Gene Delivery Systems
    • Clinical Pipeline Expansion in Rare and Genetic Disorders Accelerates Technology Adoption
    • Growing Cell and Gene Therapy Manufacturing Ecosystem Expands Demand for Scalable Delivery Tools
    • Strategic Collaborations Between Biotech and CDMOs Generate Growth in Gene Delivery Outsourcing
    • Regulatory Support for Novel Therapies Spurs Innovation in Safe and Effective Delivery Mechanisms
    • Increased Interest in Tissue- and Cell-Specific Vectors Propels Customization in Delivery Platforms
    • Technological Integration with Nanocarriers and Lipid Particles Expands Functional Capabilities
    • Use of AI and Predictive Models Enhances Precision in Vector Design and Gene Expression Control
    • Rising Investment in In Vivo Delivery for Oncology Applications Sustains Market Momentum
    • Intellectual Property and Licensing Strategies Create Barriers and Competitive Differentiation
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Gene Delivery Technologies Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Gene Delivery Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Gene Delivery Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Gene Delivery Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Biological Mode by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Biological Mode by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Biological Mode by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Chemical Mode by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Chemical Mode by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Chemical Mode by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Physical Mode by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Physical Mode by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Physical Mode by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Research Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Research Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Research Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Gene Therapy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Gene Therapy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Gene Therapy Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Cell Therapy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Cell Therapy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Cell Therapy Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Vaccines Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Vaccines Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Vaccines Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Ex Vivo Method by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Ex Vivo Method by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Ex Vivo Method by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for In Vivo Method by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for In Vivo Method by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: World 16-Year Perspective for In Vivo Method by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for In Vitro Method by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for In Vitro Method by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: World 16-Year Perspective for In Vitro Method by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Gene Delivery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
  • JAPAN
    • Gene Delivery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
  • CHINA
    • Gene Delivery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: China 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: China 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: China 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
  • EUROPE
    • Gene Delivery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Gene Delivery Technologies by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Gene Delivery Technologies by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Gene Delivery Technologies by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
  • FRANCE
    • Gene Delivery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 83: France Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: France 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: France 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: France 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
  • GERMANY
    • Gene Delivery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: Germany 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Germany 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Italy 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Italy 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Gene Delivery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 110: UK Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: UK 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: UK 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: Spain 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: Spain 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: Spain 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: Russia 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: Russia 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: Russia 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Gene Delivery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Gene Delivery Technologies by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Gene Delivery Technologies by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 16-Year Perspective for Gene Delivery Technologies by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Gene Delivery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: Australia 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: Australia 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: Australia 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
  • INDIA
    • Gene Delivery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 167: India Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: India 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: India 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: India 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: South Korea 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: South Korea 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: South Korea 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Gene Delivery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Gene Delivery Technologies by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Gene Delivery Technologies by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: Latin America 16-Year Perspective for Gene Delivery Technologies by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: Latin America 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: Latin America 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: Latin America 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 208: Argentina 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 211: Argentina 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 214: Argentina 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 217: Brazil 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 220: Brazil 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 223: Brazil 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 226: Mexico 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 229: Mexico 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 232: Mexico 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Gene Delivery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Gene Delivery Technologies by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Gene Delivery Technologies by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 244: Middle East 16-Year Perspective for Gene Delivery Technologies by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 247: Middle East 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 250: Middle East 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 253: Middle East 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 256: Iran 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 259: Iran 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 262: Iran 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 265: Israel 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 268: Israel 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 271: Israel 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 283: UAE 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 286: UAE 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 289: UAE 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
  • AFRICA
    • Gene Delivery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 301: Africa 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 304: Africa 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 307: Africa 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제